药物输注系统市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004569
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

药物输注系统市场预计在 2023 年至 2031 年期间的复合年增长率为 7.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按药物输注系统市场按产品(弹性输注系统、一次性输注系统、注射器输注系统、蠕动泵、多通道泵、患者控制镇痛泵、胰岛素泵、植入式输注系统)进行细分;给药方式(肿瘤科、糖尿病科、镇痛科、营养科、血液科、儿科、其他科);应用(静脉、皮下、动脉、硬膜外、其他科);最终用户(医院、门诊手术中心、其他科)和地域(北美、欧洲、亚太地区、中东和非洲、南美和中美)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

Insight Partners 的《药物输注系统市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

药物输注系统市场细分

 

产品

  • 弹性输注系统
  • 一次性使用输液器
  • 注射器输液系统
  • 蠕动泵
  • 多通道泵
  • 病人自控镇痛泵
  • 胰岛素泵
  • 植入式输液系统

给药方式

  • 肿瘤学
  • 糖尿病
  • 镇痛
  • 营养
  • 血液学
  • 儿科
  • 其他的

应用

  • 静脉
  • 皮下
  • 动脉
  • 硬膜外
  • 其他的

终端用户

  • 医院
  • 门诊手术中心
  • 其他的

终端用户

  • 医院
  • 门诊手术中心
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

药物输注系统市场:战略洞察

Drugs Infusion System Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

药物输注系统市场增长动力

  • 慢性病增多:糖尿病、癌症和心血管疾病等慢性病的发病率不断上升,对药物输注系统市场产生了重大影响。由于这些疾病通常需要长期的药物治疗,因此对精确、高效的药物输送系统的需求正在增加。例如,糖尿病患者数量的增加使得胰岛素泵成为必需品,从而推动了市场的增长。
  • 人口老龄化:影响市场增长的另一个重要因素是人口老龄化。老年人通常需要专门护理和长期用药,因此对能够长时间准确、安全地输送药物的输液系统的需求也随之增加。
  • 先进解决方案:随着门诊护理设施的扩大,有效的药物输注系统对于门诊治疗至关重要。随着越来越多的手术在门诊环境中进行,对可靠和有效的药物输送系统的需求正在增长。这一因素在最近一段时间内推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。

药物输注系统市场未来趋势

  • 技术进步:药物输注技术的进步(例如具有无线连接和内置安全功能的智能输注泵)提高了患者的安全性和治疗效果。这些发展提高了药物输送的精确度并减少了用药错误,从而增加了输注系统对医疗专业人员的吸引力。
  • 家庭医疗保健:家庭医疗保健服务日益普及,推动了对便携式、易于使用的药物输液设备的需求。患者更喜欢能够在家中自行给药的设备,这可以减少住院时间和医疗费用。家用便携式输液泵的普及就是这种趋势的一个例子。
  • 报销政策:由于多个国家报销立法的改善,医疗机构发现实施现代药物输液系统变得更加容易。通过鼓励医院和诊所投资尖端输液技术,这种财政援助推动了市场扩张。这一因素在最近推动了整体市场的增长,预计在预测期内将继续保持类似的趋势。

药物输注系统市场机会

  • 剂量误差减少系统 (DERS):DERS 是智能输液泵的一项功能,它结合了定制的药物库,以确保预定的输液符合指定的剂量参数。当临床医生输入的剂量偏离这些指导方针时,该技术会发出实时警报。此功能通过减少编程和输液过程中的错误来确保患者获得正确的剂量。
  • 创新和研究投资:随着无线连接的出现,智能泵现在可以直接与电子健康记录 (EHR) 等临床系统交互。由于这种连接,泵现在可以直接从患者记录中访问处方信息,无需人工编程。此外,双向连接可以将输液数据返回到 EHR,从而提高数据准确性并降低人为错误的可能性。
  • 新的治疗模式潜力:多种医疗技术可以与智能泵连接,形成闭环系统。通过将输液泵软件连接到 EHR 和条形码药物管理 (BCMA) 系统,这种互操作性可提高患者安全性。这种集成可进一步减少用药错误,从而实现精确的药物分配和输液期间的实时患者监测。

 

药物输注系统市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响药物输液系统市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的药物输液系统市场细分和地理位置。

Drugs Infusion System Market
  • 获取药物输注系统市场的区域特定数据

药物输注系统市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)7.4%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 弹性输注系统
  • 一次性使用输液器
  • 注射器输液系统
  • 蠕动泵
  • 多通道泵
  • 病人自控镇痛泵
  • 胰岛素泵
  • 植入式输液系统
按管理方式
  • 肿瘤学
  • 糖尿病
  • 镇痛
  • 营养
  • 血液学
  • 儿科
  • 其他的
按应用
  • 静脉
  • 皮下
  • 动脉
  • 硬膜外
  • 其他的
按最终用户
  • 医院
  • 门诊手术中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 美敦力
  • B. Braun Melsungen AG
  • 巴克斯特
  • 阿尔科梅德公司
  • Halyard Health, INC
  • ICU医疗公司
  • 胰岛素公司
  • 泰尔茂株式会社
  • 史密斯集团

 

药物输注系统市场参与者密度:了解其对业务动态的影响

药物输液系统市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。

在药物输注系统市场运营的主要公司有:

  1. 美敦力
  2. B. Braun Melsungen AG
  3. 巴克斯特
  4. 阿尔科梅德公司
  5. Halyard Health, INC

免责声明上面列出的公司没有按照任何特定顺序排列。


Drugs Infusion System Market

 

  • 了解药物输注系统市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了药物输注系统市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,药物输液系统市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness the second highest growth in CAGR terms?

Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period

Which region is expected to witness the highest growth?

Asia Pacific region is expected to witness the highest growth during the forecast period

What is the expected CAGR of the Drugs Infusion System Market?

The Drugs Infusion System Market is estimated to witness a CAGR of 7.4% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Medtronic
- B. Braun Melsungen AG
- Baxter
- Arcomed AG
- Halyard Health, INC
- ICU Medical Inc
- Insulet Corporation
- Terumo Corporation
- Smiths Group Plc
- Tandem Diabetes Care

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.